Strategic Partnerships, Licensing & Global Market Expansion
Commercial growth does not stop at your first market.
Healthcare innovation creates value only when it reaches new providers, new partners, and new markets.
Whether you are seeking pharmaceutical licensing opportunities, regional distribution partners, healthcare investors, OEM relationships, or expansion into the MENA healthcare market, Medix provides both the strategy and commercial execution to accelerate growth.
Common challenges
Clients typically come to us when they say:
- “We need qualified pharmaceutical or distribution partners.”
- “We do not have trusted introductions in the target market.”
- “We need to evaluate commercial fit before entering a region.”
- “We need executive-level conversations, not generic lists.”
- “We need licensing or partnership discussions to move forward.”
- “We want to expand without sounding like an export company.”
Who We Help
Healthcare organizations this solution supports.
- Pharmaceutical manufacturers
- Biotechnology companies
- Medical device manufacturers
- Diagnostics companies
- Healthcare SaaS
- Clinical AI
- Healthcare technology
- Contract manufacturers
- Private label manufacturers
- Peptide manufacturers
- Specialty pharmacies
- Healthcare investors
- Private equity portfolio companies
Commercial Growth Services
Practical commercial infrastructure, not abstract recommendations.
- Licensing strategy
- Out-licensing
- In-licensing
- Regional distribution
- Strategic partnerships
- OEM partnerships
- Private label programs
- Commercial introductions
- Healthcare market intelligence
- Distributor identification
- Executive networking
- Conference representation
- Investor introductions
- Commercial due diligence
- Market expansion strategy
- Partner qualification
U.S. to MENA Region Expansion
Built around the way healthcare decisions actually move.
Markets Covered
- Saudi Arabia
- United Arab Emirates
- Qatar
- Kuwait
- Bahrain
- Oman
- Egypt
- Jordan
Target Organizations
- Pharmaceutical companies
- Healthcare distributors
- Hospital groups
- Private hospital networks
- Government healthcare systems
- Medical device distributors
- Healthcare investors
- Regional healthcare groups
Why Medix
Why Companies Choose Medix
Unlike general business development firms, Medix understands healthcare procurement, clinical decision making, provider adoption, reimbursement, hospital buying cycles, distribution, and international healthcare markets.
This combination allows us to bridge the gap between innovation and sustainable commercial growth.
Featured case study
Curapep - International Licensing Expansion
Curapep developed VityPatch, an FDA-listed Class I hydrogel wound dressing supporting diabetic foot ulcers, chronic wounds, burns, pressure injuries, surgical recovery, and advanced wound care.
Challenge
Curapep needed qualified pharmaceutical partners with established commercial infrastructure throughout the MENA region. Finding the right partners required trusted introductions, healthcare market knowledge, and an understanding of local purchasing dynamics.
Medix Strategy
- Identified pharmaceutical organizations aligned with advanced wound care, hospital products, diabetic care, and medical device commercialization.
- Initiated executive outreach, managed licensing conversations, evaluated commercial fit, and coordinated discussions supporting long-term regional partnerships.
- Continued expanding provider adoption throughout the U.S. wound care ecosystem to support both domestic and international commercial momentum.
Results
- Qualified 25+ regional pharmaceutical organizations.
- Initiated licensing discussions across Saudi Arabia, the UAE, and Egypt.
- Developed commercial evaluation frameworks for regional partnerships.
- Built a scalable international business development process supporting future expansion.
Key lesson
Medix helps healthcare companies build markets, not simply enter them.
Next step
Ready to build a stronger healthcare growth system?
World map connecting the United States, Saudi Arabia, UAE, and Egypt with healthcare partnership icons.